TOKYO, Nov 17 (Reuters) - Japanese shares were flat on Tuesday as investors booked profits following the recent surge in the benchmark index, even as news of another promising coronavirus vaccine re-ignited hopes of a swift global recovery.
The Nikkei share average .N225 , which has gained 12.6% so far this month, was nearly flat at 25,913.41 by the midday break. It briefly touched its highest since May 1991 in early trade, tracking overnight gains on Wall Street.
The benchmark index on Monday closed at a 29-year high after the economy posted its first expansion in four quarters. market has been overheated by a high-paced rise, and it would be no wonder if stocks go into correction at any time in the short term," said Maki Sawada, equity market strategist at Nomura Securities.
The S&P 500 and Dow Jones industrial average notched record closing highs on Monday after Moderna Inc MRNA.O said its experimental COVID-19 vaccine was 94.5% effective in preventing infection based on interim late-stage data. broader Topix .TOPX eased 0.26% to 1,727.39. Nearly half of the 33 sector sub-indexes on the Tokyo exchange traded higher.
Semiconductor Tokyo Electron 8035.T rose 1.2% to a record high, taking positive cues from its U.S. peers.
Nikkei's heavyweight Fanuc Corp 6954.T rose nearly 1.8%, helped by upbeat industrial output data from China and the formation of a regional trade bloc comprising 15 Asia-Pacific economies. Mothers Index .MTHR of start-up firm shares, however, dropped 3.73%.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.